# MAGNESIUM CARBONATE

URL: https://app.greenveil.ai/ingredients/ingredient_unii_0_e53_j927_na
Categories: pharma
Identifier: cfr:21 CFR 184.1425

> MAGNESIUM CARBONATE. Route: ORAL; Dosage form: CAPSULE; Potency: 22.4 mg Assessed from 15 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: ORAL; Dosage form: CAPSULE; Potency: 22.4 mg

## Regulatory status

- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 22.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 22.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 180 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 180 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 28.5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 250 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 11.22 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 84 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 89 active drug products and 91 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._